Chlorhexidine Gluconate (CHG) Applicators, Procedural
ID: IAD-2501-05Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)
Timeline
    Description

    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking qualified vendors to supply Chlorhexidine Gluconate (CHG) Applicators, Procedural, as part of a Combined Synopsis/Solicitation. Vendors are required to submit detailed pricing and product specifications, including compliance with the Qualified Suppliers List (QSL) and adherence to the Distribution and Pricing Agreement (DAPA), to support Military Treatment Facilities (MTFs) across various branches of the military. This procurement action is crucial for standardizing medical supplies and ensuring efficient healthcare delivery within the defense sector, with an estimated annual demand valued at approximately $812,275.77. Interested vendors must submit their proposals by March 6, 2025, and can direct inquiries to Mr. Arthur B. Redmond at arthur.b.redmond.ctr@health.mil or David Sheaffer at david.v.sheaffer.ctr@health.mil.

    Point(s) of Contact
    Mr. Arthur B. Redmond MMESO Data Analyst Contractor
    arthur.b.redmond.ctr@health.mil
    David Sheaffer Project Manager Contractor
    david.v.sheaffer.ctr@health.mil
    Files
    Title
    Posted
    The Defense Health Agency (DHA) and Defense Logistics Agency (DLA) are initiating a Standardization Action (SA) for Chlorhexidine Gluconate (CHG) Applicators, Procedural, targeting vendors on the Qualified Suppliers List (QSL). The selected vendor will support Military Treatment Facilities (MTFs) across the Army, Navy, Air Force, Marine Corps, and other Defense sectors, contributing to an estimated annual demand of $812,275.77. Vendors must provide discounted pricing off the Distribution and Pricing Agreement (DAPA) and submit detailed pricing information by the deadline of March 6, 2025. The selection will favor the lowest offered price for a five-year Incentive Agreement (IA), beginning April 8, 2025. Compliance with DAPA and the requirement for QSL eligibility is crucial for participation. Vendors must maintain consistent communication with the DHA and DLA, ensuring their quotes are submitted accurately and on time. This procurement action emphasizes the government’s commitment to medical standardization and efficiency in military healthcare supplies while managing costs effectively. Non-selected vendors will be notified after the selection process.
    The Medical Materiel Enterprise Standardization Office (MMESO) seeks vendor submissions for the Chlorhexidine Gluconate (CHG) Applicators under the DoD's procurement processes. Vendors must provide detailed pricing and product data that accounts for Prime Vendor costs. The submission includes vital information such as vendor contact details and a breakdown of product specifications, with a focus on different sizes and variations of CHG applicators. Acknowledgment of fees and compliance with the Qualified Supplier List (QSL) is required. Vendors not on the QSL will not be considered, and adherence to the outlined pricing and packaging formats is crucial. The document emphasizes a structured approach for vendors, requesting a full breakdown of unit prices, purchase quantities, and product descriptions to facilitate the evaluation process for potential contracts. The purpose of this document lies in streamlining procurement for medical supplies while ensuring compliance with stringent defense requisites.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    Chlorhexidine Gluconate (CHG) Applicators, Surgical
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency's DLA Troop Support, is seeking vendors to supply Chlorhexidine Gluconate (CHG) applicators for surgical use, as part of a standardization initiative aimed at Military Treatment Facilities. Vendors must be listed on the Qualified Suppliers List and are required to submit detailed pricing information and product specifications, with the goal of establishing a sole vendor for a five-year Incentive Agreement based on the lowest price. The annual demand for these applicators is estimated at approximately $908,392.36, reflecting the importance of standardizing medical supplies within the Military Health System. Interested vendors should contact Mr. Arthur B. Redmond at arthur.b.redmond.ctr@health.mil or David Sheaffer at david.v.sheaffer.ctr@health.mil for further details and ensure compliance with submission deadlines to participate in this procurement opportunity.
    Cloth, Chlorhexidine Gluconate Pre-Op Prep
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Cloth, Chlorhexidine Gluconate Pre-Op Prep products, with a presolicitation notice expected to be released on or about February 2, 2025. This initiative aims to solicit information and evaluate products such as single-use, rinse-free cloths pre-saturated with 2% Chlorhexidine Gluconate, which are essential for skin antisepsis prior to surgical procedures. Vendors interested in participating must have a Distribution and Pricing Agreement (DAPA) and ensure their products are manufactured in a Trade Agreements Act (TAA) compliant country, with all relevant details to be made available on the SAM.gov website upon the QSL announcement. For further inquiries, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.
    Specimen Container Peel Pack
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors for the Qualified Suppliers Listing (QSL) for Specimen Container Peel Pack products intended for use in Military Treatment Facilities and operational assemblages. Vendors must possess or apply for a Distribution and Pricing Agreement (DAPA) number, maintain active registration with the System for Award Management (SAM), and have agreements with DoD Medical/Surgical Prime Vendors such as Cardinal Health and Owens & Minor. This initiative is crucial for standardizing medical supplies within the Military Health System, ensuring compliance with quality standards and regulations, including the Trade Agreements Act (TAA). Interested vendors should submit their QSL Package Worksheet and supporting documentation by August 1, 2024, and can direct inquiries to Cornelius Brother at cornelius.l.brothers.ctr@health.mil or Moises Soto at moises.soto1.ctr@health.mil.
    Pulse Oximeter-Fingertip, Aeromedical Certified
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking qualified vendors to establish a Qualified Suppliers Listing (QSL) for the MW-2406-37 Pulse Oximeter-Fingertip, Aeromedical Certified. This procurement aims to identify suppliers capable of providing aeromedical certified pulse oximeters for use in Military Treatment Facilities (MTFs) across the Military Health System (MHS), with an estimated annual sales volume of $1,293,929 based on historical data. Vendors must comply with stringent requirements, including possession of a Distribution and Pricing Agreement (DAPA), FDA compliance, and adherence to specific product specifications, with submissions due by February 20, 2025. Interested vendors should direct inquiries to Mr. Riley Whittlesey or Mr. David Sheaffer via email, ensuring all documentation is submitted by the specified deadline to be considered for inclusion in the QSL.
    Vaginal Specula Disposable
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Disposable Vaginal Specula. This initiative aims to solicit information and products for evaluation, focusing on single-use, sterile and non-sterile Pederson style vaginal specula in various sizes, which will be utilized in outpatient OB/GYN, emergency department, or urgent care settings, excluding surgical procedures. Interested vendors must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and ensure compliance with the Trade Agreements Act (TAA), with the QSL Announcement expected to be released on or about February 2, 2025. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or the MMESO Enterprise Wide Standardization at dha.detrick.med-log.mbx.mmeso@mail.mil.
    Emergency Thermal Blankets - Hypothermia Prevention
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors to create a Qualified Suppliers Listing (QSL) for Emergency Thermal Blankets designed for hypothermia prevention. This initiative aims to support Military Treatment Facilities (MTFs) within the Military Health System (MHS) and is part of the DLA's Medical Prime Vendor Program. The anticipated annual sales volume for these blankets is approximately $180,035, based on historical usage data, and vendors must comply with specific requirements, including TAA compliance, single-use specifications, and documentation regarding materials used. Interested vendors must submit their QSL Package Worksheet and supporting documentation by February 20, 2025, to Dr. Jim Quinn at james.e.quinn28.ctr@health.mil or Mr. David Sheaffer at david.v.sheaffer.ctr@mail.mil, with notifications of qualification expected by March 13, 2025.
    6505--764-25-2-077-0483 -Murfreesboro CMOP Eyelid Cleanser -(VA-25-00042430)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Eyelid Cleanser Eye Scrub Pads for the Murfreesboro Consolidated Mail Outpatient Pharmacy (CMOP). This solicitation, identified as contract number 36C77025Q0136, requires vendors to provide essential pharmaceutical supplies while adhering to strict compliance with federal regulations, including the Drug Supply Chain Security Act. The Eyelid Cleanser is a critical medical product aimed at ensuring the health and well-being of veterans, necessitating high standards of quality and traceability. Interested vendors must submit their quotes by February 19, 2025, at 3:00 PM Central Time, along with required documentation such as a signed SF1449 cover page, pricing schedule, and proof of compliance with the Buy American Act. For further inquiries, vendors can contact Contract Specialist Jennifer D. Coleman at jennifer.coleman4@va.gov.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense (DoD) is soliciting quotations for pharmaceutical agents as part of its Pharmacy Uniform Formulary Blanket Purchase Agreement and Additional Discount Program, managed by the Defense Health Agency (DHA). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on the selection and classification of pharmaceutical agents based on clinical and cost-effectiveness for military beneficiaries. The upcoming Pharmacy and Therapeutics (P&T) Committee meeting, scheduled for May 7-8, 2025, will review specific drug classes, including Breast Cancer Agents and Targeted Immunomodulatory Biologics, with quotes due by March 20, 2025. Interested vendors should direct inquiries to Tracy Banks at tracy.e.banks2.civ@health.mil or Julianne Canaley at julianne.m.canaley.ctr@health.mil for further details.
    Dimethyl Fumarate DR Presolicitation
    Buyer not available
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.